Prof. Dr. YAMAN TOKAT
|
|
|
- Stephanie Hancock
- 10 years ago
- Views:
Transcription
1 Prof. Dr. YAMAN TOKAT ADDRESS: 19 Mayıs Street, Dr. Ismet Oztürk Road, No:17, D:38, Şişli, Istanbul/TURKEY GSM: DATE OF BIRTH: BIRTH PLACE: Izmir / TURKEY LANGUAGES: Turkish, English MARITAL STATUS: Married, 1 daughter EDUCATION: Fellow in Transplantation Surgery Senior Registrar, Department of Transplantation and Hepatobiliary Surgery, Cambridge University Medical School, Cambridge / UK ( ) Resident in General Surgery Residency in General Surgery, Ege University Medical School, Department of General Surgery, Izmir / TURKEY ( ) M.D. Degree Ege University Medical School, Izmir / TURKEY ( ) PROFESSIONAL EXPERIENCE: Physician, Compulsory Medical Service, Corum / TURKEY ( ) Post-Doctoral Fellow, Sleep Disorder Center, Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA ( ) Visiting Resident, Department of General Surgery, Baylor College of Medicine, Houston, TX, USA (1987) Visiting Clinician, Department of General Surgery and Transplantation, Mayo Clinic, Rochester, MN, USA (1988) Surgical Ambassador, Oncologic Surgery, Department of General Surgery, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA (1990) Staff General Surgeon, Ege University Medical School, Department of General Surgery, Izmir/TURKEY ( ) Assistant Professor, Ege University Medical School, Department of General Surgery, Izmir/TURKEY ( ) Visiting Professor, University of Nebraska, Hepatobiliary Surgery and Transplantation Unit, USA (1996) Associate Professor in Surgery, Ege University Medical School, Department of General Surgery, Izmir/TURKEY ( ) Visiting Surgeon, University of Kyoto, Japan (1999) Professor in General Surgery, Ege University Medical School, Department of General Surgery, Izmir/TURKEY ( ) CURRENT JOB: Professor in General Surgery Director, Florence Nightingale Hospital, Department of General Surgery and Organ Transplantation, Istanbul/TURKEY 1
2 SCHOLARSHIPS AND AWARDS: Honorary Medical Graduate, Palermo and Roma Medical Faculty, Italy (1981) United States Medical Licensing Examination (USMLE) Certificate (1985) Scholarship of The Scientific and Technological Research Council of Turkey (M.D. Anderson Cancer Center Surgical Ambassador, 1990) General Medical Council, UK (Senior Registrar, 1993) MEMBERSHIPS: Turkish Liver Transplantation Society Euroasia Liver Transplantation Society (EALTS) International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) PUBLICATIONS: 1. Is Mezlocilline Prophylaxis Effective İn Clinical Renal Transplantation?, TOKAT Y.,Coker A.,Basci A.,Hoscoskun H.,Kaplan H.,Yararbas O., Transplantation Proceedings 24 (5) : 1757, Evaluation of Patients Transplanted in Countries Other Than Turkey, Coker A.,Ok E.,TOKAT Y.,Hoscoskun C.,Kaplan H.,Yararbas O., Transplantation Proceedings 26(4): , Effect of Preservation Time on Early Graft Function and Outcome of Orthotopic Liver Transplants, Rasmussen A., Chavez -Cartaya R., TOKAT Y., Jamieson N., Transplantation Proceedings 27(1) : , Relationship Between Patterns of Hepatobiliary Vascular Supply and Biliary Complications in Liver Transplantation : An Anatomical and Clinical Analysis, Saxena R., TOKAT Y., Soin A., Rasmussen A., Jamieson N., Calne R., Transplantation Proceedings 27(1): , Cyclosporine Levels İn The Early Post Transplant Period - Predictive of Chronic Rejection in Liver Transplantation, Soin A., Rasmussen A., Jamieson N., Watson C., TOKAT Y., Friend P., Calne R., Transplantation Proceedings 27(1): , Post Transplant Problems Requiring Regrafting: An Analysis of 72 Patients With 96 Liver Retransplants, TOKAT Y., Soin A., Saxena R., Watson C., Rasmussen A., Masatoshi S., Wight D., Friend P., Jamieson N., Calne R., Transplantation Proceedings 27(1): , Alloimmune Haemolytic Anemia After Renal Transplantation, Ok E., Akçiçek F., Çoker A., Tombuloğlu M., Toz H., TOKAT Y., Cirit M., Tobu M., Onder G., Bascı A., Nephrology, Dialysis, Transplantation. 10: , Gastrointestinal Complications in Renal Transplantation, TOKAT Y., Zeytunlu M., Kılıc M., Kaplan H., Yararbas O., Transplantation Proceedings Vol 28, No:4(August), , Tuberculosis After Renal Transplantation, TOKAT Y., Kılıç M., Ok E., Kurşat S., Sayıner A., Tanıl V., Başçı A., Transplantation Proceedings Vol 28, No: 4, , Segmental Arteries to Segments 1-4 from the Common Hepatic Artery, Saxena R., TOKAT Y., Rasmussen A., Jamieson N., Calne R., British Journal of Surgery, 82: , Donor Arterial Variations in Liver Transplantation:Management and Outcome of 527 Consecutive Grafts, Soin A., Friend PJF, Rasmussen A., Saxena R., TOKAT Y., Alexander GJM, Jamieson NV., Calne RY., British Journal of Surgery, 83: , Goitre and Severe Autonomic Neuropathy due to Secondary Amyloidosis in a Renal Transplant Patient, Ok E., Akçiçek F., Töz H., Coker A., Kürşat S., TOKAT Y., Arac N., Clinical Nephrology 45(5) : 1-2, The Reproducibility of Cyclosporin Induced Hemolytic Uremic Syndrome in a Renal Allograft Recipient, Ok E., Kürşat S., TOKAT Y., Cirit M., Tombuloğlu M., Akçiçek F., Nephron ; 74 : 238, Further Evidence of Favourable Effects of Gemfibrozil on Lipid Profile in Renal Allograft Recipients, Ok E., Kürşat S., Alev M., Tobu M., TOKAT Y., Akçiçek F., Hoşcoşkun C., Başçı A., Nephron; 73 : , Nocardiosis in Renal Transplant Patients, Kürşat S., Ok E., Zeytinoğlu A., TOKAT Y., Saydam G., Cirit M., Akçiçek F., Nephron 75: ,
3 16. Haemophagocytic-histiocytic Syndrome in Renal Transplantation, Kürşat S., Çağırgan S., Ok E., Ünsal A., TOKAT Y., Saydam G., Akçiçek F., Başçı A., Nephrology Dialysis Transplantation, 12 ; , Oesophagocoloplasty in the Management of Postcorrosive Strictures of the Oesophagus, Yararbas O., Osmanoglu H.,Kaplan H.,TOKAT Y.,Coker A., Korkut M., Hepato Gastroenterology 45, 59-64, Open Surgical Technique for Thoracal and Thoracoabdominal Aortic Aneurysms, Buket S., TOKAT Y., Çalkavur T., Alayunt A.,Sarıbülbül O., Durmaz İ., Asian Journal of Surgery, Vol 21, No 2: , ATG Versus OKT3 in the Treatment of Steroid Resistant Rejection Following Living Related Donor Renal Transplantation, Uslu A., TOKAT Y., Ok E., Unsal A., Ilkgul O., Kaplan H., Transplantation Proceedings, 29, (1997) 20. Surgical Management of Vesicoureteral Reflux Following Renal Transplantation, TOKAT Y., Uslu A., Ok E., Tunçyürek P., Çelik A., Yararbas Ö., Transplantation Proceedings, 29, (1997) 21. Impact of Extreme Donor Age on the Outcome of Living Related Donor Kidney Transplantation, Uslu A., TOKAT Y., Ok E., Unsal A., Celik A., Yalaz S., Kaplan H., Transplantation Proceedings 30, , Clinicopathological Features of Rapidly Progressive Hepatitis C Virus Infection in HCV Antibody Negative Renal Transplant Recipients, Ok E., Unsal A., Celik A., Zeytinoglu A., Ersoz G., TOKAT Y.,Erensoy S., Akarca U., Bascı A., Yuce G Nephrology Dialysis Transplantation 13 : , Tuberculosis in Renal Transplant Recipients, Sayiner A.,Ece T., Duman S., Yıldız A., Ozkahya M. Kilicaslan Z. TOKAT Y., Transplantation 1999 Nov 15 ; 68(9) : Circulatory Arrest to Protect Transplant Kidney in a Patient with Chronic Type III Dissection, Yagdı T., Buket S., TOKAT Y., Posacıoglu H., Askar F., Ann. Vasc Surg 15 (5): Sept New Frontiers; Adult to Adult Living Donor Liver Transplantation, Single Center Experience From Turkey TOKAT Y, Yuzer Y., Karasu Z., Alper M., Killi R., Zeytunlu M., Yılmaz F., Transplantation Proceedings, December, 33 ; , Idiopathic Hepatic Adenoma with Intratumoral Hemorrhage, Günsar F., Aydın A., TOKAT Y., Elmas N. European Journal of Gastroenterology and Hepatology, 14(4) : , April Mycobacterium Tuberculosis Infection and Laboratory Diagnosis in Solid Organ Transplant Recipients Cavusoglu C., Cicek-Saydam C., Karasu Z., Karaca Y., Ozkahya M., Toz H., Tokat Y., Bilgiç A., Clin Transplant 2002 Aug;16(4) : Immediate Tracheal Extubation of the Liver Transplant Recipients in the Operating Room, Transplant Proc Dec;34(8):3334-5, Ulukaya S., Ayanoglu HO,Acar L., Tokat Y., Kilic M. 29. Optimal Venous Drainage for Right Lobe Living Donor Grafts, Zeytunlu M.,Icoz G., Kilic M., Yuzer Y.,Tokat Y.Transplant Proc 2002 Dec34(8); Biliary Complications Encountered in 50 Adult to Adult Right Lobe Living Donor Liver Transplantation, Icoz G., Kilic M., Yuzer Y., Zeytunlu M., Tokat Y., Liver Transplantation, In Press 31. Donor safety in adult-to-adult living donor liver transplantation. Transplant Proc Jun;35(4): Zeytunlu M, Icoz G, Kilic M, Demirbas T, Tokat Y, Yuzer Y. 32. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc Jun;35(4): Ayanoglu HO, Ulukaya S, Tokat Y. 33. Roux-en-Y bleeding after living donor liver transplantation: a novel technique for surgical treatment. Transplant Proc Jun;35(4): Icoz G, Kilic M, Zeytunlu M, Yaprak O, Arikan C, Yuzer Y, Tokat Y. 34. Hemophagocytic syndrome after living-related liver transplantation. Transplant Proc Jun;35(4): Karasu Z, Kilic M, Cagirgan S, Lebe E, Yilmaz F, Demirbas T, Tokat Y. 35. Large-volume paracentesis and liver transplantation. J Pediatr Gastroenterol Nutr Aug;37(2): No abstract available. Arikan C, Ozgenc F, Akman SA, Yagci RV, Tokat Y, Aydogdu S. 36. Anesthetic management and complications in living donor hepatectomy. Transplant Proc Dec;35(8): Ayanoglu HO, Ulukaya S, Yuzer Y, Tokat Y. 37. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc Dec;35(8): Nart D, Arikan C, Akyildiz M, Yuce G, Demirpolat G, Zeytunlu M, Karasu Z, Aydogdu S, Killi R, Yuzer Y, Tokat Y, Kilic M. 3
4 38. Liver transplantation in a patient with Budd-Chiari syndrome secondary to factor V Leiden mutation. Transplant Proc Dec;35(8): Karasu Z, Nart D, Lebe E, Demirbas T, Memis A, Kilic M, Akyildiz M, Tokat Y. 39. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy. Transplant Proc Dec;35(8): Arikan C, Kilic M, Tokat Y, Aydogdu S. 40. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J Trop Pediatr Dec;49(6): Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV. 41. Immediate tracheal extubation of pediatric liver transplant recipients in the operating room. Pediatr Transplant Oct;7(5): Ulukaya S, Arikan C, Aydogdu S, Ayanoglu HO, Tokat Y. 42. Stage IV hepatic encephalopathy associated with acute blindness after liver transplantation. Pediatr Transplant Dec;7(6): Arikan C, Tekgul H, Egilmez S, Kilic M, Yagci RV, Tokat Y, Aydogdu S. 43. Regenerative nodule mimicking hepatocellular carcinoma in a cirrhotic child due to hepatitis B: an imaging dilemma. Pediatr Transplant Apr;8(2): Ozgenc F, Aydogdu S, Aksoylar S, Elmas N, Yuce G, Yagci RV, Tokat Y. 44. Biliary atresia in Turkish children. Pediatr Int Apr;46(2): Aydogdu S, Ozgenc F, AtIk T, Unal F, Tokat Y, Yagci RV. 45. Effect of portal venous injection of donor spleen cells on skin allograft survival in rat. Indian J Med Res Mar;119(3): Kara E, Gokhan I, Dayangac M, Ilkgul O, Ertan H, Tokat Y, Terzioglu E. 46. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation. Transplant Proc Jun;36(5): Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, Ersoz G, Akarca U, Batur Y, Tokat Y. 47. Rituximab therapy for life-threatining immune hemolytic anemia in a liver tranplant recipient: a case report. Transplant Proc Jun;36(5): Akyildiz M, Karasu Z, Cagirgan S, Kilic M, Tokat Y. 48. A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal hemorrhage. Turk J Gastroenterol Jun;15(2): Ilkgul O, Icoz G, Dayangac M, Tokat Y, Ozutemiz O. 49. Recipient-derived hepatocytes in sex-mismatched liver allografts after liver transplantation: early versus late transplant biopsies. Transplantation Dec 15;78(11): Idilman R, Erden E, Kuzu I, Ersoz S, Karasu Z, Karayalcin K, Yuce G, Tokat Y, Sahin Y, Tukun A, Akarca US, Karayalcin S. 50. Impact of liver transplantation on renal function of patients with congenital hepatic fibrosis associated with autosomal recessive polycystic kidney disease. Pediatr Transplant Dec;8(6): Arikan C, Ozgenc F, Akman SA, Kilic M, Tokat Y, Yagci RV, Aydogdu S. 51. Variations of hepatic veins: helical computerized tomography experience in 100 consecutive living liver donors with emphasis on right lobe. Transplant Proc Nov;36(9): Orguc S, Tercan M, Bozoklar A, Akyildiz M, Gurgan U, Celebi A, Nart D, Karasu Z, Icoz G, Zeytunlu M, Yuzer Y, Tokat Y, Kilic M. 52. Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin. Transplant Proc Nov;36(9): Akay S, Karasu Z, Akyildiz M, Tokat Y. 53. Cytokine gene polymorphism and early graft rejection in liver transplant recipients. Transplant Proc Nov;36(9): Karasu Z, Ulukaya S, Ayanoglu HO, Basturk B, Ulukaya E, Akyildiz M, Tokat Y. 54. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation. Antivir Ther Dec;9(6): Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y. 55. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence. J Viral Hepat Mar;12(2): Karasu Z, Ozacar T, Akarca U, Ersoz G, Erensoy S, Gunsar F, Kobat A, Tokat Y, Batur Y. 56. Successful treatment of liver transplant-associated Kaposi's sarcoma with long-term vincristine. Transplant Proc Jun;37(5): Akay S, Karasu Z, Akyildiz M, Tokat Y, Goker E. 57. Experience with mesocaval shunt with autologous jugular vein interposition in patients with Budd-Chiari syndrome. Hepatogastroenterology May-Jun;52(63): Ilkgul O, Kilic M, Icoz G, Zeytunlu M, Demirpolat G, Akyildiz M, Tokat Y, Parildar M, Memis A. 4
5 58. Outcome of pediatric liver transplant recipients in Turkey: single center experience. Pediatr Transplant Dec;9(6): Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, Yagci RV, Tokat Y. 59. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Pediatr Transplant Feb;10(1):42-7. Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, Yagci RV, Aydogdu S. 60. Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication. Dig Dis Sci Feb;51(2): No abstract available. Oruc N, Tokat Y, Killi R, Tombuloglu M, Ilter T. 61. The prevention of bone fractures after liver transplantation: experience with alendronate treatment. Transplant Proc Jun;38(5): Atamaz F, Hepguler S, Karasu Z, Kilic M, Tokat Y. 62. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol Aug;18(8): Colak Y, Karasu Z, Oruc N, Can C, Balym Z, Akarca U, Gunsar F, Ersoz G, Tokat Y, Batur Y. 63. Umut Ozcan M, Ocal S, Basdogan C, Dogusoy G, Tokat Y. Characterization of frequency-dependent material properties of human liver and its pathologies using an impact hammer. Med Image Anal Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Use of middle hepatic vein in right lobe living donor liver transplantation. Transplant Int 2010; 23(3): Duran C, Uraz S, Kantarci M, Ozturk E, Doganay S, Dayangac M, Bozkurt M, Yuzer Y, Tokat Y. Hepatic arterial mapping by multidetector computed tomographic angiography in living donor liver transplantation. J Comput Assist Tomogr Jul-Aug;33(4): Balci D, Taner B, Dayangac M, Akin B, Yaprak O, Duran C, Uraz S, Hayzaran S, Ayanoglu O, Killi R, Senturk H, Yuzer Y, Tokat Y. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report. Transplant Proc Jun;40(5): Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Donor safety and remnant liver volume in living donor liver transplantation. Liver Transpl Aug;14(8): Uraz S, Duran C, Balci D, Akin B, Dayangac M, Kurt Z, Ayanoglu OH, Killi R, Yuzer Y, Tokat Y. A very rare venous anomaly in a living liver donor: left hepatic venous connection to the right atrium.transplant Proc. 2007;39(5): Duran C, Taner B, Dayangac M, Akin B, Balci D, Kurt Z, Killi R, Yuzer Y, Tokat Y. Why we did not use this donor. Liver Transpl (8): Sirvanci M, Duran C, Ozturk E, Balci D, Dayangac M, Onat L, Yüzer Y, Tokat Y, Killi R. The value of magnetic resonance cholangiography in the preoperative assessment of living liver donors. Clin Imaging. 2007;31(6): Karasu Z, Akyildiz M, Zeytunlu M, Noyan A, Yuzer Y, Tokat Y, Kilic M. Urgent adult-to-adult right lobe living donor liver transplantation for acute liver failure; a single center experience from Turkey. Hepatogastroenterology Apr-May;54(75): Duran C, Aydinli B, Tokat Y, Yuzer Y, Kantarci M, Akgun M, Polat KY, Unal B, Killi R, Atamanalp SS. Stereological evaluation of liver volume in living donor liver transplantation using MDCT via the Cavalieri method. Liver Transpl May;13(5): Analysis of Right Lobe Livin-Donor Liver Complications: A Single center experience. Yaprak O, Dayangac M, Demirbas BT, Tabandeh B, Yuzer Y, Tokat Y. Experimental and Clinical Transplantation (2011)1: Utilization of elderly donors in living donor liver transplantation : When more is less? Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y. Liver Traspl May; 17 (5): Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation. Yaprak O, Dayangaç M, Balcı D, Demirbaş T, Yuzer Y, Tokat Y. Hepatogastroenterology Sep - Oct ; 57 ( ) : Hepatitis B prophylaxis in living donor liver transplantation : single center experience. Yaprak O, Dayangaç M, Balcı D, Baş K, Yuzer Y, Tokat Y. Hepatogastroenterology Sep - Oct; 57 ( ) :
6 77. Dual left lobe living donor liver transplantation using donors unacceptable for right lobe donation : a case report. Dayangaç M, Taner CB, Akin B, Uraz S, Balcı D, Duran C, Ayanoğlu O, Killi R, Yuzer Y, Tokat Y. Transplant Proc Dec ; 42 (10) : Yaprak O, Demirbas T, Duran C, Dayangac M, Akyildiz M, Tokat Y, Yuzer Y. Living donor liver hilar variations: surgical approaches and implications. Hepatobiliary Pancreat Dis Int. 2011; 10(5): Yaprak O, Balci NC, Dayangac M, Demirbas T, Guler N, Ulusoy L, Tokat Y, Yuzer Y. Aortic patch Cryopreserved aortic quilt plasty for one-step reconstruction of multiple hepatic venous drainage in right lobe living donor liver transplantation. Transplant Proc. 2011; 43(7): Balci D, Dayangac M, Yaprak O, Akin B, Duran C, Killi R, Yuzer Y, Tokat Y. Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria. Transpl Int. 2011; 24(11): ABSTRACTS AND PRESENTATIONS: 1. Is Meslocilline Prophylaxis Effective in Clinical Renal Transplantation?, TOKAT Y., Coker A., Bascı A., Hoscoskun C., Kaplan H., Yararbas O., 1st International Congress on Transplantation in Developing Countries, Singapore 1992(Oral presentation) 2. Riedel's Thyroiditis, Yetkin E.,Coker A.,TOKAT Y.,Kabalak T., Eurosurgery,3rd European Congress of Surgery, London 1993(Poster) 3. Is Living Related Donor Nephrectomy Innocent?, TOKAT Y.,Gurkan A.,Coker A.,Hoscoskun C.,Kaplan H.,Yararbas O., Cınar T., Eurosurgery, 3rd European Congress of Surgery, London 1993(Poster) 4. Evaluation of Patients Transplanted in Countries Other Than Turkey, Coker A.,Ok E.,TOKAT Y.,Hoscoskun C.,Kaplan H.,Yararbas O., 3rd Congress of Asian Society Of Transplantation, Bangkok 1993(Oral presentation) 5. Effect of Preservation Time on Early Graft Function and Outcome of Orthotopic Liver Transplants, Rasmussen A., Chavez -Cartaya R., TOKAT Y., Jamieson N., 15th Congress of International Society of Organ Transplantation, Kyoto, Japan 1994(Oral presentation) 6. The Relationship Between Patterns of Hepatobiliary Vascular Supply and Biliary Complications in Liver Transplantation : An Anatomical and Clinical Analysis, Saxena R., TOKAT Y., Soin A., Rasmussen A., Jamieson N., Calne R., 15th Congress of International Society of Organ Transplantation, Kyoto, Japan 1994(Oral presentation) 7. Cyclosporine Levels İn The Early Post Transplant Period - Predictive of Chronic Rejection in Liver Transplantation, Soin A., Rasmussen A., Jamieson N., Watson C., TOKAT Y., Friend P., Calne R., 15th Congress of International Society of Organ Transplantation, Kyoto, Japan, 1994(Oral presentation) 8. Post- Transplant Problems Requiring Regrafting: An Analysis of 72 Patients With 96 Liver Retransplants, Masatoshi S., TOKAT Y., Soin A., Saxena R., Watson C., Rasmussen A., Wight D., Friend P., Jamieson N., Calne R., 15th Congress of International Society of Organ Transplantation, Kyoto, Japan, 1994(Oral presentation) 9. Incidence, Management and Outcome of Donor Arterial Variations in Liver Grafts - An Analysis of 527 Consecutive Grafts, Soin AS., Friend PJ., Rasmussen A., Saxena R., TOKAT Y., Jamieson NV., Calne RY., British Transplantation Society Meeting, London, England 1994(Oral presentation) 10. Causes of Early Graft Failure After Orthotopic Liver Transplantation, TOKAT Y., Rasmussen A., Watson C., Saxena R., Soin A., Friend P., Jamieson, N., Calne R., 10th Biennial Congress of Asian Surgical Association, Bali, Indonesia 1995(Oral presentation) 11. Surgical Treatment of Thoracoabdominal Aneurysms: Video Presentation, Buket S., TOKAT Y., Alayunt A., Tarım E., Çalkavur T., Durmaz I., 10th Biennial Congress of Asian Surgical Association, Bali, Indonesia 1995(Oral presentation) 12. Comparison of the effect of Laparoscopic Moncrief- Popovich Technique (LMPT) an Conventional Blind Trocar(BTT) Technique on Early CAPD Complications, Akçiçek F., Ok E., TOKAT Y; Cirit M., Kürşat S., Töbü M., Ünsal A., Atabay G., Başçı A., 32nd Congress of the European Dialysis and Transplantation Association, Athens, Greece, 1995(Oral presentation) 6
7 13. Open Surgical Technique For Thoracal/Thoracoabdominal Aortic Aneuryms, Buket S., TOKAT Y., Alayunt A., Çalkavur T., Durmaz İ., European Congress of Surgery (EUROSURGERY), Barcelona 1995(Oral presentation) 14. Surgical Management of Vesicoureteral Reflux Following Renal Transplantation, TOKAT Y., Ok E., Tunçyürek P., Kürşat S., Hoşcoşkun C., Sözbilen M., Yararbaş Ö., 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 15. Tuberculosis Following Renal Transplantation, TOKAT Y., Ok E., Kılıç M., Kürşat S., Akçiçek F., Sayıner A., Kaplan H., 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 16. Treatment of Hyperlpidemia in Renal Allograft Recipients with Gemfibrosil, Ok E., Kürşat S., Alev M., Töbü M., TOKAT Y., Akçiçek F., Hoşcoşkun, Atabay G., 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 17. Diltiazem Effects on Cyclosporine Using Recipients of Living Related Kidney Grafts, Ok E., Akçiçek F., Kürşat S., Töbü M., Önder G., TOKAT Y., Çoker A., Başçı, 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 18. Nocardiosis in Renal Transplant Patients, Kürşat S., Ok E., TOKAT Y., Saydam G., Pamukçuoğlu F., Cirit M., Akçiçek F., 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 19. Malignencies in Renal Transplant Patients, Kürşat S., Ok E., TOKAT Y., Akçiçek F., Cirit M., Hoşcoşkun C., Kaplan, Başçı A., 6th Asian Pasific Congress of Nephrology, Hong Kong 1995(Oral presentation) 20. Thoracoscopy in the Diagnosis and Treatment of Both Mediastinal and Pulmonary Diseases, TOKAT Y., Kılıc M., Zeytunlu M., Moğulkoç N., Ersin S., Uslu A., Yararbas O., First joint Eruro Asian Congress for Endoscopic Surgery, Istanbul 1997(Poster) 21. Surgical Complications During Laparoscopic Cholecystectomy, TOKAT Y., Zeytunlu M., Kılıç M., Ersin S., Coker A.,Yararbaş O., European Congress of the International Hepato-Pancreato-Biliary Association, Hamburg (Oral presentation) 22. Laparoscopic Management of Peritoneal Dialysis Catheters, Ersin S,. Zeytunlu M., Uslu A.,Kılıç M., Akçiçek F.,Yılmaz M., TOKAT Y., 6th World Congress of Endoscopic Surgery Rome,Italy 1998(Oral presentation) 23. A Refined Approach to the Repair of Bile Duct Stiructures, Yuzer Y., TOKAT Y., Yaprak O., Zeytunlu M., Congress of International HepatoPancreato Biliary Association, Amsterdam 2001(Oral presentation) 24. Single Center Experience in Adult to Adult Living Related Liver Transplantation from Turkey, TOKAT Y., Yuzer Y., Karasu Z., Alper M., Killi R., Aydogdu S., Congress of International HepatoPancreato Biliary Association, Amsterdam 2001(Oral presentation) 25. Five Year Experience with Surgical Treatment of Budd-Chiari Syndrome in a Transplantation Center, TOKAT Y., Yuzer Y., Sukru K., Zeytunlu M., Congress of International HepatoPancreato Biliary Association, Amsterdam 2001(Poster) 26. Extended Right Hepatic Lobectomy in a patient with Hepatocelluler Carcinoma and Tumor Thrombus in Inferior Vena Cava, Yuzer Y., TOKAT Y., Dayangac M., Zeytunlu M., Yılmaz f., Tekeşin O., Congress of International HepatoPancreato Biliary Association, Amsterdam 2001(Poster) 27. Biliary Complications in Living Related Liver Transplantation, İcoz G., Kurt Z., Yuzer Y., TOKAT Y., Eight Congress of the International Liver Transplantation Society,June2002 Chicago(Poster) 28. Bleeding from the Roux en Y Limb After Living Related Donor Liver Transplantation, Icoz G., Kılıc M., Unalp O., Karasu Z., Yuzer Y., TOKAT Y, Eight Congress of the International Liver Transplantation Society,June2002 Chicago(Poster) 29. How Small is Too Small? Outcome of the Small for Size Allografts in Living Donor Liver Transplantation, Kılıc M., Zeytunlu M., Karasu Z., Icoz G., Yuzer Y., TOKAT Y, Eight Congress of the International Liver Transplantation Society,June2002 Chicago(Poster) 30. Hemophagocytic Syndrome After Living Related Donor Liver Transplantation, Karasu Z., Kılıc M., Keskin E., Guler N., Cagırgan S., Lebe E., Kılıcsoy N., Yuzer Y., TOKAT Y., Eight Congress of the International Liver Transplantation Society,June2002 Chicago(Poster) 31. Optimal Venous Drainage for Right Lobe Living Donor Liver Grafts, TOKAT Y., Zeytunlu M., Icoz G., Kılıc M., Demirbas T., Yuzer Y., XIX International Congress of The Transplantation Society, August 2002, Miami(Poster) 7
8 32. Factors That Effect the Rate of Donation, Bozoklar A., Sozbilen M., Kılıc M., Zeytunlu M., Icöz G., TOKAT Y. XIX International Congress of The Transplantation Society, August 2002, Miami(Oral presentation) 33. Microsurgical Reconstruction of Hepatic Artery in Living Donor Liver Transplantation, Alper M., Gündogan H., Ozek C., Kılıc M., Zeytunlu M., Icoz G., Yuzer Y., TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami (Poster) 34. Factors That Effect the Rate of Donation, Bozoklar A., Sozbilen M., Kılıc M., Zeytunlu M., Icöz G., TOKAT Y. XIX International Congress of The Transplantation Society, August 2002, Miami 35. Microsurgical Reconstruction of Hepatic Artery in Living Donor Liver Transplantation, Alper M., Gündogan H., Ozek C.,Kılıc M., Zeytunlu M., Icoz G., Yuzer Y.,TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 36. Donor Safety ın Rıght Lobe Lıvıng Donor Lıver Transplantatıon, Zeytunlu M, Yuzer Y, Icoz G, TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 37. Biliary Complications in Living Related Liver Transplantation, Kılıc M, Icoz G, Kurt Z, Yuzer Y, TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 38. Outcome of the Small For Size Allografts In Living Donor Liver Transplantation, G. Icoz, M Kilic, M. Zeytunlu, O. Yaprak, N.Guler, Z.Karasu,Y.Yuzer, TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 39. Adult to Adult Living Donor Transplantation;Experience of A Single Center in Turkey, TOKAT Y., Zeytunlu M.,KarasuZ.,Aydogdu S., Icoz G,Kılıc M., Yuzer Y., XIX International Congress of The Transplantation Society, August 2002, Miami 40. Induction of Immunosupression with Mycophenolate Mofetil and Steroids and Avoidance of Calcineurin Antagonists for the First Three Days After Orthotopic Liver Transplantation, Kılıc M.,Keskin E., Lebe E.,Kilincsoy N., Karasu Z., Icoz G,Zeytunlu M., Yuzer Y., TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 41. Early Postoperatıve Infections in Pediatric Liver Transplant Recipients, Arikan C.,Ozgenc F.,Aydogdu S., TOKAT Y.,Yagcı R., XIX International Congress of The Transplantation Society, August 2002, Miami 42. Comparision of FK-506 with Cyclosporin for Primary Immunsupression After Liver Transplantation in Children, Ozgenc F.,Aydogdu S., Arikan C., Yagcı R,TOKAT Y., XIX International Congress of The Transplantation Society, August 2002, Miami 43. Small-for-size graft liver transplantation: can smaller size grafts be used? Akin EB, Uraz S, Balci D, Dayangac M, Kurt Z, Duran C, Ayanoglu O, Killi R, Yuzer Y, Tokat Y. Joint International Cogress of the ILTS, ELITA, and LICAGE. May 3-6, 2006, Milan, Italy. 44. The role of MRCP assessing biliary anatomy in adult-to-adult living related liver transplant donors. Duran C, Akin B, Balci D, Dayangac M, Kurt Z, Taman O, Killi R, Yuzer Y, Tokat Y. Joint International Cogress of the ILTS, ELITA, and LICAGE. May 3-6,2006, Milan, Italy. 45. Hepatitis B prophylaxis using combination of low dose hepatitis B immunglobulin and lamivudine in liver transplantation. Balci D, Akin B, Dayangac M, Kurt Z, Uraz S, Senturk H, Yuzer Y, Tokat Y. Joint International Cogress of the ILTS, ELITA, and LICAGE. May 3-6, 2006, Milan, Italy. 46. Orthotopic liver transplantation for hepatic hemangioendothelioma. Uraz S, Balci D, Akin B, Dayangac M, Kurt Z, Duran C, Killi R, Yuzer Y, Senturk H, Tokat Y. Joint International Cogress of the ILTS, ELITA, and LICAGE. May 3-6, 2006, Milan, Italy. 47. Using marginal right lobe living liver donors: safety of expanding the margins. Murat Dayangac, Burcin C Taner, Baris Akin, Deniz Balci, Suleyman Uraz, Cihan Duran, Refik Killi, Omer Ayanoglu, Yildiray Yuzer, Yaman Tokat. 13th Congress of the European Society for Organ Transplantation. 29 Sep-3 Oct 2007, Czech Republic. 48. Living donor liver transplantation for patients with hepatocellular carcinoma within and below Milan criteria. Deniz Balci, Burcin C Taner, Murat Dayangac, Baris Akin, Cihan Duran, Suleyman Uraz, Huseyin Sen, Refik Killi, Omer Hilmi Ayanoglu, Hakan Senturk, Yildiray Yuzer, Yaman Tokat. 13th Congress of the European Society for Organ Transplantation. 29 Sep-3 Oct 2007, Czech Republic. 8
9 49. small remnant liver volume after right lobe living donor hepatectomy: outcome of donors with a remnant liver volume of less than 30%. Murat Dayangac, Burcin Taner, Deniz Balci, Zahide Kurt, Suleyman Uraz, Omer ayanoglu, Cihan Duran, Yildiray Yuzer. International Liver Transplantation Society 13th Annual International Congress, June 20-23, 2007, Rio de Janeiro, Brazil. 50. Donor safety in donor right hepatectomy with the inclusion of middle hepatic vein in living donor liver transplantation. Burcin Taner, Murat Dayangac, Deniz Balci, Zahide Kurt, Baris Akin, Suleyman Uraz, Cihan Duran, Sameer Smadi, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, June 20-23, 2007, Rio de Janeiro, Brazil. 51. Arterial reconstruction in living donor liver transplantation: analysis of 100 consecutive cases with 1 arterial thrombosis. Deniz Balci, Burcin C. Taner, Izzet Memi, Murat Dayangac, Baris Akin, Zahide Kurt, Cihan Duran, Huseyin Sen, Sanjay S. Negi, Omer H. Ayanoglu, Yildiray Yuzer, Refik Killi, Yaman Tokat, Levent Yalcin. International Liver Transplantation Society 13th Annual International Congress, June 20-23, 2007, Rio de Janeiro, Brazil. 52. First dual left lobe liver transplantation in Turkey. Burcin Taner, Murat Dayangac, Baris Akin, Deniz Balci, Zahide Kurt, Omer Ayanoglu, Cihan Duran, Refik Killi, Suleyman Uraz, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, June 20-23, 2007, Rio de Janeiro, Brazil. 53. Living donor liver transplantation for patients with hepatocellular carcinoma: Expanded criteria or more. Deniz Balci, Burcin C. Taner, Murat Dayangac, Baris Akin, Zahide Kurt, İzzet memi, Cihan Duran, Suleyman Uraz, Huseyin Sen, Omer H. Ayanoglu, Refik Killi, Levent Yalcin, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, June 20-23, 2007, Rio de Janeiro, Brazil. 54. Late salvage of occluded arteriovenous fistulae: importance of venous mapping for operative planning. Akin B, Taner B, Dayangac M, Ipek C, Sitar G, Kurtoglu K, Balci D, Tokat Y. 5th International Congress of the Vascular Access Society, June 2007, Nice, France. 55. Factors affecting early outcome after upper extremity arteriovenous fistula revision. Akin B, Dayangac M, Taner B, Kurtoglu K, Ipek C, Sitar G, Balci D, Tokat Y. 5th International Congress of the Vascular Access Society, June 2007, Nice, France. 56. A database program for hemodialysis patient follow up; using computer technology for better communication between the surgeon and nephrologists. Akin B, Dayangac M, Taner B, Sitar G, Kurtoglu K, Ipek C, Balci D, Tokat Y. 5th International Congress of the Vascular Access Society, June 2007, Nice, France. 57. The sites of stricture in radiocephalic and brachiocephalic arteriovenous fistulae. Akin B, Taner B, Dayangac M, Sitar G, Kurtoglu K, Ipek C, Balci D, Tokat Y. 5th International Congress of the Vascular Access Society, June 2007, Nice, France. 58. Venovenostomy for repair of isolated proximal cephalic vein stenosis at brachiocephalic arteriovenous fistula. Akin B, Taner B, Dayangac M, Kurtoglu K, Ipek C, Balci D, Tokat Y. 5th International Congress of the Vascular Access Society, June 2007, Nice, France. 59. Living donor liver transplantation for hepatocellular carcinoma. Yaman Tokat, Murat Dayangac, Deniz Balcı, Onur Yaprak, Koray Baş, Cihan Duran, Barış Akın, Refik Killi, Yıldıray Yüzer. 18th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, October 8-11, 2008, Istanbul, Turkey. 60. Prophylaxis of HBV after living donor liver transplantation. Onur Yaprak, Murat Dayangac, Koray Bas, Suleyman Uraz, Yildiray Yuzer, Yaman Tokat. 18th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, October 8-11, 2008, Istanbul, Turkey. 61. Extended criteria donors in living donor liver transplantation. Murat Dayangac, Cemal B. Taner, Deniz Balci, Onur Yaprak, Cihan Duran, Suleyman Uraz, Baris E. Akin, Omer H. Ayanoglu, Refik Killi, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, July 9-12, 2008, Paris, France. 62. The impact of middle hepatic vein harvest on remnant liver regeneration in right liver donors: a prospective study. Murat Dayangac, Cemal B. Taner, Onur Yaprak, Cihan Duran, Baris E. Akin, Omer H. 9
10 Ayanoglu, Refik Killi, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, July 9-12, 2008, Paris, France. 63. Urgent vs. elective donor preparation in adult LDLT. Burcin Taner, Murat Dayangac, Baris Akin, Deniz Balci, Suleyman Uraz, Cihan Duran, Refik Killi, Omer Ayanoglu, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 13th Annual International Congress, July 9-12, 2008, Paris, France. 64. Two-year follow-up of microsurgical hepatic arterial reconstructions with intraoperative doppler evaluation in living donor liver transplantation: redo when necessary. Deniz Balci, Burcin C. Taner, Murat Dayangac, Baris Akin, Onur Yaprak, Derya Selamoglu, Cihan Duran, Suleyman Uraz, Huseyin Sen, Sitki Hayzaran, Refik Killi, Yildiray Yuzer, Yaman Tokat, Levent Yalcin. International Liver Transplantation Society 13th Annual International Congress, July 9-12, 2008, Paris, France. 65. Living donor liver transplantation using right liver graft with hemangiomatosis: case report. Murat Dayangac, Onur Yaprak, Koray Bas, Levent Ulusoy, Cihan Duran, Refik Killi, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 15th Annual International Congress, July 8-11, 2009, New York, USA. 66. Prospective comparative study of liver regeneration in right lobe living donor liver transplantation. Murat Dayangac, Cemal B Taner, Onur Yaprak, Koray Bas, Levent Ulusoy, Cihan Duran, Baris E Akin, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 15th Annual International Congress, July 8-11, 2009, New York, USA. 67. Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation. Onur Yaprak, Murat Dayangac, Koray Bas, Deniz Balci, Sahem Al Qusous, Yildiray Yuzer, Yaman Tokat. International Liver Transplantation Society 15th Annual International Congress, July 8-11, 2009, New York, USA. 68. Impact of anterior sector drainage on liver regeneration in living donor liver transplantation. Murat Dayangac, Deniz Balci, Burcin Taner, Onur Yaprak, Yildiray Yuzer, Yaman Tokat. The Liver Meeting,Oct 29 - Nov 2, 2010, Boston, USA. 69. Remnant liver regeneration after donor right hepatectomy. M. Dayangac. XIII National Surgical Congress with International Participation, October 7-10, 2010, Sofia, Bulgaria. 70. Analysis of right lobe living liver donor complications: single center experience. O. Yaprak, M. Dayangac, B. Tolga Demirbas, B. Tabandeh, Y Yuzer, Y. Tokat. XIII National Surgical Congress with International Participation, October 7-10, 2010, Sofia, Bulgaria. 71. Utilization of Elderly Donors in Living Donor Liver Transplantation: When More Is Less? Murat Dayangac, Burcin C. Taner, Deniz Balci, Onur Yaprak, Tolga Demirbas, Yaman Tokat, Yildiray Yuzer. International Liver Transplantation Society 16th Annual International Congress, July, 2010, Hong Kong, China. 72. Prospective randomized trial of intermittent portal triad clamping vs. no clamping in donor right hepatectomy. Murat Dayangac, Burcin C Taner, Deniz Balci, Cihan Duran, Baris Akin, Refik Killi, Yildiray Yuzer, Yaman Tokat. American Transplant Congress, April 30-May 4, 2010, San Diego, USA. 73. A single center experience: treatment of HCC with transplantation, prognostic factor analysis. Yildiray Yuzer, Onur Yaprak, Murat Dayangac, Fisun Bulutcu, Levent Yalcin, Gulen Bulbul Dogusoy, Nuray Bassulu, Tolga Demirbas, Necdet Guler, Refik Killi, Yaman Tokat. The 2011 Joint International Congress of ILTS, ELITA, and LICAGE, June 22-25, 2011, Valencia, Spain. 74. Remnant liver regeneration after donor right hepatectomy. Murat Dayangac, Deniz Balci, Onur Yaprak, Tolga Demirbas, Levent Ulusoy, Yaman Tokat, Yildiray Yuzer. The 2011 Joint International Congress of ILTS, ELITA, and LICAGE, June 22-25, 2011, Valencia, Spain. 75. Which incision is better for living donor right hepatectomy? Midline, J-shaped or Mercedes. Tolga Demirbas, Fusun Bulutcu, Yildiray Yuzer, Onur Yaprak, Murat Dayangac, Yaman Tokat. The 2011 Joint International Congress of ILTS, ELITA, and LICAGE, June 22-25, 2011, Valencia, Spain. 76. Liver transplantation for HCC: do we need new criteria for better survival? Murat Dayangac. The 2nd Congress of Euro-Asian Liver Transplantation Society, April 13-16, 2011, Bucharest, Romania. 10
Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco
Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok
Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US
Curriculum Vitae SHAHRYAR HASHEMZADEH. Qualifications. Work Experiences
SHAHRYAR HASHEMZADEH Curriculum Vitae Given Name: Shahryar Surname: Hashemzadeh Gender: Male Date of Birth: 25/8/1964 Place of Birth: Khoy, West Azerbaijan, Iran Nationality: Iranian Language: Persian,
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 1 st TURKISH-HELLENIC POSTGRADUATE CONTINUOUS MEDICAL EDUCATION MEETING MAY 6-9, 2011, IZMIR, TURKEY DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E.
Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)
Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service
Surveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
UCLA Asian Liver Program
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL HEPATOCELLULAR CARCINOMA GI Site Group Hepatocellular Carcinoma Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION
renal transplantation: A single-center comparative study
Impact of posterior urethral valves on pediatric renal transplantation: A single-center comparative study BY Mohamed Kamal Gheith, MD Oberarzt die Urologie, Universitätsmedizin Mainz Ass. Prof. of Urology,
4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care
Transplant Journey Lynette Fix, RN, BAN, CCTC Objectives Identify key components of transplant evaluation process Identify the patient follow-up process Describe diseases indicated for transplantation
NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
Wake Forest School of Medicine Department of General Surgery
Wake Forest School of Medicine Department of General Surgery TRANSPLANT SURGERY RESIDENT CURRICULUM (PGY-3) OVERVIEW This curriculum has largely been adapted from the curriculum for transplant surgery
Resection, Reduction, and Revision of Aneurysmal AV Fistulas
Resection, Reduction, and Revision of Aneurysmal AV Fistulas Patrick R. Cook DO, FACS Timothy G. Canty Jr. MD Robert J. Hye MD, FACS Kaiser Permanente San Diego, CA Aneurysmal AVF Over last decade K-DOQI
Evaluation and Prognosis of Patients with Cirrhosis
Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重
CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery
CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL
1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia
PUBLICATIONS, ABSTRACTS AND PRESENTATIONS : 1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia 2. Endovascular management of the suprarenal IVC agenesis 3. The
Colon Polyps and the Prevention of Colorectal Cancer
Colon Polyps and the Prevention of Colorectal Cancer Omer Engin Editor Colon Polyps and the Prevention of Colorectal Cancer Editor Omer Engin Department of Surgery Izmir Buca Hospital Buca, Izmir Turkey
Indications in Hepatology and Liver Diseases
exclusively working in Health Care sananet GmbH Tilo Stolzke Breite Str. 6-8 23562 Lübeck Germany Telefon : +49 451 400 8301 Telefax : +49 451 400 8302 E-Mail : [email protected] Internet : www.sananet.com
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology
LIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
How To Organize A Liver Transplantation Day In In\U00F6N\U00Fc
INVITATION LETTER Transplantation is one of the most challenging, the most promising and complex areas of medicine. İinönü University Turgut Özal Medical Center is one of the leading centers in the world
AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation
AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation Karen F. Murray and Robert L. Carithers, Jr. Preamble These recommendations provide a data-supported
Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations. Chapter. Grade. CQ No. 1 Interferon Therapy
Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations Chapter Chapter 1 Prevention Sectio n CQ No. 1 Interferon Therapy Clinical Question 1 Does interferon
BACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado
Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.
Leading the Way to Treat Liver Cancer
Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale
DOCTORS HOSPITAL AT RENAISSANCE CANCER CENTER Sarada Gummadi, M.D. Medical Oncology/Hematology
Sarada Gummadi, M.D. Medical Oncology/Hematology in Medical Oncology, Hematology and Internal Medicine. Dr. Gummadi completed her hematology/ oncology fellowship and internal medicine residency at Louisiana
Hepatocellular Carcinoma: What the hepatologist wants to know
Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have
Treatment of Hepatic Neoplasm
I. Policy University Health Alliance (UHA) will reimburse for treatment of hepatic neoplasm outside of systemic chemotherapy alone when determined to be medically necessary and within the medical criteria
The State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV
Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum
Focus on Transplantation: Treatment Post-transplant for HBV and HCV
Focus on Transplantation: Treatment Post-transplant for HBV and HCV The Viral Hepatitis Congress, Frankfurt, 09. September 2012 Christoph Sarrazin J. W. Goethe-University Hospital Medizinische Klinik I
Multidiciplinary Management of Gastrointestinal Cancers. September 5-6, 2015, Radisson Blu Hotel Sisli- Istanbul AGENDA
Multidiciplinary Management of Gastrointestinal s September 5-6, 2015, Radisson Blu Hotel Sisli- Istanbul AGENDA Saturday, 5 September 2015 08:45 Welcome and Introduction Hakan Akbulut MD. Cem Börüban
GRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
Kidney Transplantation
ilearning about your health Kidney Transplantation www.cpmc.org/learning What is Kidney Failure? Normally, kidneys filter waste products from your blood, control the balance of salt and water in your body,
AORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005
AORTOENTERIC FISTULA Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA diagnosis and management Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA Aortoenteric
A Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY
BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology
Cirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products
Dear Healthcare Provider: Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) has been mandated by the FDA (Food and Drug Administration) due to postmarketing reports showing that exposure to
The Need for Accurate Lung Cancer Staging
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
Department of Gastrointestinal Surgery Hospital Clínic i Provincial de Barcelona Villarroel, 170 Barcelona 08036
Personal Information Name: Address: Dr. Antonio M. Lacy Fortuny Chief of Gastrointestinal Surgery Hospital Clínic, Barcelona Department of Gastrointestinal Surgery Hospital Clínic i Provincial de Barcelona
LIVER TUMORS PROFF. S.FLORET
LIVER TUMORS PROFF. S.FLORET NEOPLASM OF LIVER PRIMARY 1)BENIGN 2)MALIGNANT METASTATIC/SECONDARY LIVER Primary Liver Cancer the Second Killer among tumors high morbidity and mortality(20.40/100,000) etiology
Jonathan R. Gottlieb, MD 7220 SW 127 Street Pinecrest, FL 33156 [email protected]
Jonathan R. Gottlieb, MD 7220 SW 127 Street Pinecrest, FL 33156 [email protected] CURRENT PRACTICE September 2009-present University of Miami School of Medicine Assistant Professor, Department of
CMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
: MURALIDHARAN MANIKESI Date of Birth : 24 th June 1966
CURRICULUM VITAE PERSONAL DETAILS Name : MURALIDHARAN MANIKESI Date of Birth : 24 th June 1966 Sex : Male Address : X-Block, No.43, 5 th Main Road, Anna Nagar, Chennai 600 040. Telephone : +91 44 26284276
Components of CVC Care Bundle. selection
Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis
Open Ventral Hernia Repair
Ventral Hernias Open Ventral Hernia Repair UCSF Postgraduate Course in General Surgery Maui, HI March 21, 2011 Hobart W. Harris, MD, MPH Ventral Hernias: National Experience Occur following 11-23% of laparotomies,
The Whipple Procedure. Sally Hodges, Ph.D.(c) Given the length and difficulty of the procedure, regardless of the diagnosis, certain
The Whipple Procedure Sally Hodges, Ph.D.(c) Preoperative procedures Given the length and difficulty of the procedure, regardless of the diagnosis, certain assurances must occur prior to offering a patient
PANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR703.013
PANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR703.013 COVERAGE: A simultaneous or combined pancreas-kidney transplant (SPK) from a cadaver donor or a simultaneous
Clinical Governance Development Committee October 2007 Dr Foster RTM Alerts Progress Report
Clinical Governance Development Committee October 2007 Dr Foster RTM Alerts Progress Report 1. Background Information 1.1. Initial review of the tool in November 2006, and subsequent queries in January
The Fatal Pulmonary Artery Involvement in Behçet s Disease
The Fatal Pulmonary Artery Involvement in Behçet s Disease Dr. Vedat Hamuryudan Div. Rheumatology, Dept. Internal Medicine Cerrahpasa Medical Faculty, University of Istanbul 33 years old man Sept 2011:
CURRICULUM VITAE. Office Address: 25 Courtenay Drive, 7100A Office Phone: (843) 876-4266 Charleston, SC 29425 Office Fax: (843) 876-4878
CURRICULUM VITAE Name: Rana C. Pullatt, MD, M.S., MRCS, FACS Office Address: 25 Courtenay Drive, 7100A Office Phone: (843) 876-4266 Charleston, SC 29425 Office Fax: (843) 876-4878 Education: Madras Medical
Lymphomas after organ transplantation
Produced 21.03.2011 Revision due 21.03.2011 Lymphomas after organ transplantation People who have undergone an organ transplant are more at risk of developing lymphoma known as post-transplant lymphoproliferative
Hepatitis C and Liver Transplantation. Dinesh Ranjan, M.D. Professor of Surgery Director of Liver Transplantation University of Kentucky
Hepatitis C and Liver Transplantation Dinesh Ranjan, M.D. Professor of Surgery Director of Liver Transplantation University of Kentucky History Known as Non-A A Non-B B Hepatitis in 1974 HCV identified
Translocation Renal Cell Carcinomas
Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)
Where World-Class Expertise and Genuine Compassion Come Together. AT THE FOREFRONT OF TRANSPLANT CARE Kidney Combined Kidney-Pancreas Pancreas Islets
Where World-Class Expertise and Genuine Compassion Come Together 0011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000 000010111000101110011000110100111100110111100000101010011000101100010111000010010000100010000100
Kidney and Pancreas Transplant Evaluation Clinics and Committee: Inpatient Nephrology Transplant Consult Service
Care of Renal Transplant Patients takes place in five distinct practice settings at the University of Michigan: a) Kidney and Pancreas Pre-transplant evaluation clinics (five half-day clinics per week)
HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
November 24-28, 2014 Grosseto, Italy
CLINICAL ROBOTIC SURGERY ASSOCIATION LET'S KEEP IN TOUCH TO IMPROVE OUR ROBOTIC CLINICAL PRACTICE November 24-28, 2014 Grosseto, Italy CRSA EUROPEAN CHAPTER HPB - COLORECTAL DIRECTOR OF THE SCHOOL AND
Preliminary Program 9th EDS Postgraduate Course Riga, Latvia May 14-16, 2015
Preliminary Program 9th May 14-16, 2015 Venue: Riga city Bellevue Park Hotel Riga, Slokas iela 1, Rīga, Latvia Thursday, May 14, 2015 Time 14:00-14:20 Workshop: Evidence Based Medicine (limited to 35 participants)
How To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
Acute Abdominal Pain following Bariatric Surgery. Disclosure. Objectives 8/17/2015. I have nothing to disclose
Acute Abdominal Pain following Bariatric Surgery Kathy J. Morris, DNP, APRN, FNP C, FAANP University of Nebraska Medical Center College of Nursing Disclosure I have nothing to disclose Objectives Pathophysiology
Enzyme Replacement Therapies for UCD (Liver/ Liver Cell / Stem Cell Transplantation) Pat McKiernan Birmingham Children s Hospital
Enzyme Replacement Therapies for UCD (Liver/ Liver Cell / Stem Cell Transplantation) Pat McKiernan Birmingham Children s Hospital Survival following liver transplantation for Biliary Atresia at BCH (n=195)
Tunneled Hemodialysis Catheters: Placement and complications
Tunneled Hemodialysis Catheters: Placement and complications Arif Asif, M.D. Director, Interventional Nephrology Associate Professor of Medicine University of Miami, FL Tunneled Hemodialysis Catheters:
What is Vascular Surgery Worth to a Health Care System?
What is Vascular Surgery Worth to a Health Care System? Peter Gloviczki, MD Robert Zwolak, MD Sean Roddy, MD Conflict of Interest NONE Mayo Clinic, Rochester, MN, Dartmouth-Hitchcock Medical Center, Lebanon,
Bile Leaks After Laparoscopic Cholecystectomy. Kings County Hospital Center Eliana A. Soto, MD
Bile Leaks After Laparoscopic Cholecystectomy Kings County Hospital Center Eliana A. Soto, MD Biliary Injuries during Cholecystectomy In the 1990s, high rate of biliary injury was due in part to learning
Heart transplantation
Heart transplantation A patient s guide 1 Heart transplantation Heart transplantation has the potential to significantly improve the length and quality of life for patients with severe heart failure.
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA
CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA WHAT IS CANCER OF THE LIVER? Hepatocellular carcinoma is the most common form and it comes from the main type of liver cell, the hepatocyte. About 3 out 4
Case Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute
A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute Click to view Biosketch and Presentation Abstract or page down to review presentation
Hepatocellular Carcinoma Treatment Decision Tree
Treatment Decision Tree Derek DuBay, MD Assistant Professor of Surgery Liver Transplant and Hepatobiliary Surgery UAB Department of Surgery 1 UAB Liver Tumor Clinic Referrals: 205 996 5970 (phone) 205
Hepatocellular Carcinoma (HCC)
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
Catheter Embolization and YOU
Catheter Embolization and YOU What is catheter embolization? Embolization therapy is a minimally invasive (non-surgical) treatment that occludes or blocks one or more blood vessels or vascular channels
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
Advanced Robotic Course: UPPERGI HPB ENDOCRINE
International School of Robotic Surgery In Partnership with INTERNATIONAL NETWORK OF ROBOTIC SCHOOLS ACOI Special School of Robotic Surgery DIRECTOR OF THE SCHOOL AND COURSES Piercristoforo Giulianotti
Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name
Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy Patient Name Please read this form carefully and ask about anything you may not understand. I consent to have a laparoscopic Vertical Sleeve
Master of Physician Assistant Studies Course Descriptions for Year I
FALL TERM COURSES: Master of Physician Assistant Studies Course Descriptions for Year I PHAC 7230 Fundamentals in Pharmacology for Health Care I Credit Hrs: 3 This course will build on foundational knowledge
Resection of Lung Cancer Invading the Mediastinum
Resection of Lung Cancer Invading the Mediastinum Philippe G. Dartevelle MARIE-LANNELONGUE HOSPITAL GUSTAVE ROUSSY INSTITUTE INSTITUTE OF THORACIC ONCOLOGY PARIS SUD UNIVERSITY Mediastinal Invasion Superior
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
